chapter 46

27
Chapter 46 Care of Patients with Problems of the Peripheral Nervous System Mrs. Marion Kreisel MSN, RN NU230 Adult Health 2 Fall 2011

Upload: sondra

Post on 05-Jan-2016

20 views

Category:

Documents


0 download

DESCRIPTION

Chapter 46. Care of Patients with Problems of the Peripheral Nervous System. Mrs. Marion Kreisel MSN, RN NU230 Adult Health 2 Fall 2011. Guillain-Barré Syndrome. Demyelination of the peripheral nerves, progressive motor weakness and sensory abnormalities Ascending paralysis - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Chapter 46

Chapter 46

Care of Patients with Problems of the Peripheral Nervous System

Mrs. Marion Kreisel MSN, RNNU230 Adult Health 2Fall 2011

Page 2: Chapter 46

Guillain-Barré Syndrome

• Demyelination of the peripheral nerves, progressive motor weakness and sensory abnormalities

• Ascending paralysis• Result of a variety of related immune-

mediated pathologic processes

Page 3: Chapter 46

Clinical Manifestations• Muscle weakness and pain have abrupt

onset; cause remains obscure.• Cerebral function or pupillary signs are not

affected.• Cranial nerve involvement.• Autonomic dysfunction.• Weakness and paresthesia begin in the

lower extremities and progress upward toward the trunk, arms, and cranial nerves in ascending GBS.

Page 4: Chapter 46

Interventions

• Drug therapy• Plasmapheresis • Monitoring respiratory status and

managing the airway• Managing cardiac dysfunction• Improving mobility and preventing

complications of immobility• Managing pain• Promoting communication• Providing emotional support

Page 5: Chapter 46

Plasmapheresis

• Plasmapheresis removes the circulating antibodies assumed to cause the disease.

• Plasma is selectively separated from whole blood; the blood cells are returned to the patient without the plasma.

• Plasma usually replaces itself, or the patient is transfused with albumin.

Page 6: Chapter 46

Myasthenia Gravis

• Chronic disease characterized by weakness primarily in muscles innervated by cranial nerves, as well as in skeletal and respiratory muscles

• Thymoma—encapsulated thymus gland tumor

• Progressive paresis of affected muscle groups that is partially resolved by resting

• Most common symptoms—involvement of eye muscles, such as ocular palsies, ptosis, diplopia, weak or incomplete eye closure

Page 7: Chapter 46

Tensilon Testing

• Within 30 to 60 sec after injection of Tensilon, most myasthenic patients show marked improvement in muscle tone that lasts 4 to 5 minutes.

• Prostigmin is also used.• Cholinergic crisis is due to overmedication.• Myasthenic crisis is due to

undermedication.• Atropine sulfate is the antidote for Tensilon

complications.

Page 8: Chapter 46

Nonsurgical Management

• Respiratory support• Promoting mobility• Drug therapy:

• Cholinesterase inhibitor drugs• Immunosuppression• Plasmapheresis

Page 9: Chapter 46

Cholinesterase Inhibitor Drugs

• Drugs include anticholinesterase and antimyasthenics.

• Enhance neuromuscular impulse transmission by preventing decrease of ACh by the enzyme ChE.

• Administer with food.• Observe drug interactions.

Page 10: Chapter 46

Emergency Crises

• Myasthenic crisis—an exacerbation of the myasthenic symptoms caused by undermedication with anticholinesterases

• Cholinergic crisis—an acute exacerbation of muscle weakness caused by overmedication with cholinergic (anticholinesterase) drugs

Page 11: Chapter 46

Myasthenic Emergency Crisis

• Tensilon test is performed.• Priority for nursing management is to

maintain adequate respiratory function.• Cholinesterase-inhibiting drugs are

withheld because they increase respiratory secretions and are usually ineffective for the first few days after the crisis begins.

Page 12: Chapter 46

Cholinergic Emergency Crisis

• Anticholinergic drugs are withheld while the patient is maintained on a ventilator.

• Atropine may be given and repeated, if necessary.

• Observe for thickened secretions due to the drugs.

• Improvement is usually rapid after appropriate drugs have been given.

Page 13: Chapter 46

Management

• Immunosuppression• Plasmapheresis• Respiratory support• Promoting self-care guidelines• Assisting with communication• Nutritional support• Eye protection• Surgical management usually involving

thymectomy

Page 14: Chapter 46

Health Teaching

• Factors in exacerbation include infection, stress, surgery, hard physical exercise, sedatives, enemas, and strong cathartics.

• Avoid overheating, crowds, overeating, erratic changes in sleeping habits, and emotional extremes.

• Teach warning signs.• Teach importance of compliance.

Page 15: Chapter 46

Peripheral Nerve Trauma

• Vehicular or sports injury or wounds to the peripheral nerves

• Degeneration and retraction of the nerve distal to the injury within 24 hours

• Perioperative and postoperative care• Rehabilitation through physiotherapy

Page 16: Chapter 46

Peripheral Nerves

Page 17: Chapter 46

Peripheral Nerve Injury

Page 18: Chapter 46

Restless Legs Syndrome

• Leg paresthesias associated with an irresistible urge to move; commonly associated with peripheral and central nerve damage in the legs and spinal cord

• Management—symptomatic, involving treating the underlying cause or contributing factor, if known

• Nonmedical treatment• Drug therapy effective for some patients

Page 19: Chapter 46

Trigeminal Neuralgia

• Affects trigeminal or fifth cranial nerve• Nonsurgical management of facial pain—

drug therapy• Surgical management—microvascular

decompression, radiofrequency thermal coagulation, percutaneous balloon microcompression

• Postoperative care—monitoring for complications

• Characterized by intermittent episodes of severe pain with sudden onset

Page 20: Chapter 46

Trigeminal Nerve

Page 21: Chapter 46

Facial Paralysis or Bell’s Palsy

• Acute paralysis of seventh cranial nerve• Medical management—prednisone,

analgesics, acyclovir• Protection of the eye• Nutrition • Massage; warm, moist heat; facial

exercises• Pt education important: Usually symptoms

disappear or get better within a few weeks

Page 22: Chapter 46

NCLEX TIME

Page 23: Chapter 46

Question 1

Who is the typical patient who develops myasthenia gravis?

A. A man whose age of onset is between 60 and 70 years

B. A woman whose age of onset is between 20 and 30 years

C. A man whose age of onset is between 40 and 50 years

D. A woman whose age of onset is between 40 and 50 years

Page 24: Chapter 46

Question 2

Which assessment variable is the best early indicator of compromised neurovascular function?

A. Pallor B. Decreased pulses C. Tingling sensation D. Coolness of the extremity

Page 25: Chapter 46

Question 3

The effects of chemotherapy-induced peripheral neuropathy are expected to be:

A. Temporary and short-livedB. Dose-limiting and may cause permanent

disability C. Controlled with steroids such as

prednisone D. Not dose-limiting but may cause

temporary disability

Page 26: Chapter 46

Question 4

What conditions might the nurse expect to see in the patient with restless leg syndrome?

A. Diabetes and renal failureB. Peripheral vascular disease and multiple

sclerosis C. Myasthenia gravis and decreased visionD. Trigeminal neuralgia and facial paralysis

Page 27: Chapter 46

Question 5

A patient complains of eye dryness and acute pain of her face and behind her ear. The nurse should perform a focused assessment of which cranial nerve?

A. III B. V C. VIID. VIII